Anterior gradient 2 is a novel pro-tumor factor in pancreatic cancer under NF-κB subunit RelA trans-regulation that can be suppressed by eugenic acid

This publication has 31 references indexed in Scilit:

• Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation
  BMC Cancer, 2013
• Targeting the NF-κB Pathway in Cancer Therapy
  Surgical Oncology Clinics of North America, 2013
• PLK1 Is Transcriptionally Activated by NF-κB during Cell Detachment and Enhances Anoikis Resistance through Inhibiting β-Catenin Degradation in Esophageal Squamous Cell Carcinoma
  Clinical Cancer Research, 2011
• Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG
  Life Sciences, 2010
• Pancreatic Cancer
  New England Journal of Medicine, 2010
• Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 2009
• Anterior Gradient 2 Is Expressed and Secreted during the Development of Pancreatic Cancer and Promotes Cancer Cell Survival
  Cancer Research, 2008
• Isoeugenol suppression of inducible nitric oxide synthase expression is mediated by down-regulation of NF-κB, ERK1/2, and p38 kinase
  European Journal of Pharmacology, 2007
• Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis
  International Journal of Cancer, 2004
• Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity
  Bioorganic & Medicinal Chemistry, 2003